Epoxyeicosanoid signaling in CNS function and disease.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Prostaglandins & other lipid mediators

• Publication date

  2010-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.prostaglandins.2009.06.004PMID 19545642PMCID PMC2844927
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Soluble Epoxide Hydrolase Inhibition: Targeting Multiple Mechanisms of Ischemic Brain Injury with a Single Agent.

  2009cited by this paper
• Differential subcellular distribution and colocalization of the microsomal and soluble epoxide hydrolases in cultured neonatal rat brain cortical astrocytes

  2009cited by this paper
• Epoxyeicosatrienoic Acids Function as Selective, Endogenous Antagonists of Native Thromboxane Receptors: Identification of a Novel Mechanism of Vasodilation

  2009cited by this paper
• Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels.

  2009cited by this paper
• Tissue specific basal expression of soluble murine epoxide hydrolase and effects of clofibrate on the mRNA levels in extrahepatic tissues and liver

  2009cited by this paper
• A Cytochrome P450-Derived Epoxygenated Metabolite of Anandamide Is a Potent Cannabinoid Receptor 2-Selective Agonist

  2009cited by this paper
• Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide

  2008cited by this paper
• Characterization of Epoxyeicosatrienoic Acid Binding Site in U937 Membranes Using a Novel Radiolabeled Agonist, 20-125I-14,15-Epoxyeicosa-8(Z)-Enoic Acid

  2008cited by this paper
• Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study

  2008cited by this paper
• A Common Polymorphism G-50T in Cytochrome P450 2J2 Gene Is Associated with Increased Risk of Essential Hypertension in a Russian Population

  2008cited by this paper
• Mechanotransducers in Rat Pulpal Afferents

  2008cited by this paper
• Antinociception Produced by 14,15-Epoxyeicosatrienoic Acid Is Mediated by the Activation of β-Endorphin and Met-Enkephalin in the Rat Ventrolateral Periaqueductal Gray

  2008cited by this paper
• Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke

  2008cited by this paper
• Epoxygenases and peroxisome proliferator‐activated receptors in mammalian vascular biology

  2008cited by this paper
• Cytochrome P-450 metabolites of 2-arachidonoylglycerol play a role in Ca 2-induced relaxation of rat mesenteric arteries

  2008cited by this paper
• Identification of Novel Endogenous Cytochrome P450 Arachidonate Metabolites with High Affinity for Cannabinoid Receptors*

  2008cited by this paper
• Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis

  2008cited by this paper
• Antiangiogenic Effect of Inhibitors of Cytochrome P450 on Rats with Glioblastoma Multiforme

  2008cited by this paper
• Cytochrome P-450 metabolites of 2-arachidonoylglycerol play a role in Ca2+-induced relaxation of rat mesenteric arteries.

  2008cited by this paper
• Soluble Epoxide Hydrolase Gene Deletion Is Protective Against Experimental Cerebral Ischemia

  2008cited by this paper
• Genetic variation in cytochrome P450 2J2 and soluble epoxide hydrolase and risk of ischemic stroke in a Chinese population

  2008cited by this paper
• Soluble epoxide hydrolase: regulation by estrogen and role in the inflammatory response to cerebral ischemia.

  2008cited by this paper
• Role of cytochrome P450-dependent transient receptor potential V4 activation in flow-induced vasodilatation.

  2008cited by this paper
• Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways

  2008cited by this paper
• The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile

  2008cited by this paper
• Distribution and Expression of Soluble Epoxide Hydrolase in Human Brain

  2008cited by this paper
• Tone-dependent vascular responses to astrocyte-derived signals.

  2008cited by this paper
• Genetic Variation in Soluble Epoxide Hydrolase (EPHX2) Is Associated With an Increased Risk of Ischemic Stroke in White Europeans

  2008cited by this paper
• Transient receptor potential vanilloid 4 mediates protease activated receptor 2-induced sensitization of colonic afferent nerves and visceral hyperalgesia.

  2008cited by this paper
• The -50G>T polymorphism in the promoter of the CYP2J2 gene in coronary heart disease: the Ludwigshafen Risk and Cardiovascular Health study.

  2007cited by this paper
• Roles of Transient Receptor Potential Vanilloid Subtype 1 and Cannabinoid Type 1 Receptors in the Brain: Neuroprotection versus Neurotoxicity

  2007cited by this paper
• Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk.

  2007cited by this paper
• The risk of myocardial infarction in patients with reduced activity of cytochrome P450 2C9

  2007cited by this paper
• Sequence variation in the soluble epoxide hydrolase gene and subclinical coronary atherosclerosis: interaction with cigarette smoking.

  2007cited by this paper
• Anandamide Metabolism by Human Liver and Kidney Microsomal Cytochrome P450 Enzymes to Form Hydroxyeicosatetraenoic and Epoxyeicosatrienoic Acid Ethanolamides

  2007cited by this paper
• Action of epoxyeicosatrienoic acids on cellular function.

  2007cited by this paper
• Soluble Epoxide Hydrolase: A Novel Therapeutic Target in Stroke

  2007cited by this paper
• Cytochrome P450 Eicosanoids are Activators of Peroxisome Proliferator-Activated Receptor α

  2007cited by this paper
• Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs).

  2007cited by this paper
• CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study

  2007cited by this paper
• A novel role for P450 eicosanoids in the neurogenic control of cerebral blood flow

  2007cited by this paper
• PPARgamma as a therapeutic target in central nervous system diseases.

  2006cited by this paper
• Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction.

  2006cited by this paper
• Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain.

  2006cited by this paper
• Cytochrome P450 Cyp4x1 is a major P450 protein in mouse brain

  2006cited by this paper
• Astrocyte-mediated control of cerebral blood flow

  2006cited by this paper
• Distribution of soluble epoxide hydrolase, cytochrome P450 2C8, 2C9 and 2J2 in human malignant neoplasms

  2006cited by this paper
• Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury.

  2006cited by this paper
• Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease.

  2006cited by this paper
• Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors

  2006cited by this paper
• Perivascular nerves and the regulation of cerebrovascular tone.

  2006cited by this paper
• Glial Cells Dilate and Constrict Blood Vessels: A Mechanism of Neurovascular Coupling

  2006cited by this paper
• Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders.

  2006influential reference
• PPARγ as a therapeutic target in central nervous system diseases

  2006cited by this paper
• Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.

  2006cited by this paper
• Role of astrocytes in cerebrovascular regulation.

  2006cited by this paper
• The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase.

  2005cited by this paper
• Modulation of the Ca2 Permeable Cation Channel TRPV4 by Cytochrome P450 Epoxygenases in Vascular Endothelium

  2005cited by this paper
• Epoxide hydrolases: their roles and interactions with lipid metabolism.

  2005cited by this paper
• The Prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension.

  2005cited by this paper
• Influence of cytochrome P450 2C9*2 and 2C9*3 variants on the risk of ischemic stroke: a cross-sectional case-control study.

  2005cited by this paper
• Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries.

  2005cited by this paper
• TRPV4 Forms a Novel Ca2+ Signaling Complex With Ryanodine Receptors and BKCa Channels

  2005cited by this paper
• Localization of rat cytochrome P450 in various tissues and comparison of arachidonic acid metabolism by rat P450 with that by human P450 orthologs.

  2005cited by this paper
• Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.

  2005cited by this paper
• Hypoxic Preconditioning and Tolerance via Hypoxia Inducible Factor (HIF) 1α-linked Induction of P450 2C11 Epoxygenase in Astrocytes

  2005cited by this paper
• Identification and characterisation of soluble epoxide hydrolase in mouse brain by a robust protein biochemical method

  2005cited by this paper
• Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors.

  2005cited by this paper
• Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients.

  2005cited by this paper
• Cytochrome P450 in neurological disease.

  2004cited by this paper
• Membrane Potential-Dependent Inhibition of Platelet Adhesion to Endothelial Cells by Epoxyeicosatrienoic Acids

  2004cited by this paper
• Calcium transients in astrocyte endfeet cause cerebrovascular constrictions

  2004cited by this paper
• Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred

  2004cited by this paper
• Risk of Coronary Artery Disease Associated With Polymorphism of the Cytochrome P450 Epoxygenase CYP2J2

  2004cited by this paper
• Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.

  2004cited by this paper
• Prostaglandins & other lipid mediators: a new phase, a new team.

  2004cited by this paper
• CYP2C9*2 and CYP2C9*3 alleles confer a lower risk for myocardial infarction.

  2004cited by this paper
• CYP2C9 allele variants in Chinese hypertension patients and healthy controls.

  2004cited by this paper
• Dependency of Cortical Functional Hyperemia to Forepaw Stimulation on Epoxygenase and Nitric Oxide Synthase Activities in Rats

  2004cited by this paper
• Enhanced Postischemic Functional Recovery in CYP2J2 Transgenic Hearts Involves Mitochondrial ATP-Sensitive K+ Channels and p42/p44 MAPK Pathway

  2004cited by this paper
• Signaling at the Gliovascular Interface

  2003cited by this paper
• 11,12-Epoxyeicosatrienoic Acid-induced Inhibition of FOXO Factors Promotes Endothelial Proliferation by Down-Regulating p27Kip1*

  2003cited by this paper
• 12-Epoxyeicosatrienoic Acid-induced Inhibition of FOXO Factors Promotes Endothelial Proliferation by Down-Regulating p 27 Kip 1 *

  2003cited by this paper
• Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels

  2003cited by this paper
• Polymorphisms in human soluble epoxide hydrolase.

  2003cited by this paper
• Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.

  2003cited by this paper
• Cerebral Capillary Endothelial Cell Mitogenesis and Morphogenesis Induced by Astrocytic Epoxyeicosatrienoic Acid

  2002cited by this paper
• Neuroprotection and P 450 2 C 11 Upregulation After Experimental Transient Ischemic Attack

  2002cited by this paper
• Neuroprotection and P450 2C11 Upregulation After Experimental Transient Ischemic Attack

  2002cited by this paper
• Suppression of cortical functional hyperemia to vibrissal stimulation in the rat by epoxygenase inhibitors.

  2002cited by this paper
• Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle.

  2002cited by this paper
• The CYP4A Isoforms Hydroxylate Epoxyeicosatrienoic Acids to Form High Affinity Peroxisome Proliferator-activated Receptor Ligands*

  2002cited by this paper
• Identification of a novel cytochrome P450, CYP4X1, with unique localization specific to the brain.

  2002cited by this paper
• P-450 metabolites of arachidonic acid in the control of cardiovascular function.

  2002cited by this paper
• Dual regulation of the cerebral microvasculature by epoxyeicosatrienoic acids.

  2001cited by this paper
• Pathways of Epoxyeicosatrienoic Acid Metabolism in Endothelial Cells

  2001cited by this paper
• Cytochrome P450 Epoxygenase Metabolism of Arachidonic Acid Inhibits Apoptosis

  2001cited by this paper
• The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signalling pathways and proliferation in vascular cells

  2001cited by this paper
• Epoxygenase Pathways of Arachidonic Acid Metabolism*

  2001cited by this paper
• Activation of Gαs Mediates Induction of Tissue-type Plasminogen Activator Gene Transcription by Epoxyeicosatrienoic Acids*

  2001cited by this paper

• Reducing degradation of EETs by sEH protein macromolecule depletion prevents MCAO and inhibits microglia-mediated inflammatory response.

  2025cites this paper
• The soluble epoxide hydrolase inhibitor TPPU alleviates Aβ-mediated neuroinflammatory responses in Drosophila melanogaster and cellular models of alzheimer’s disease

  2025cites this paper
• Recent insights in the importance of limonene and its biotransformed value added compounds

  2025cites this paper
• Molecular mechanisms of cytochrome P450-derived epoxy-fatty acids neuroprotection.

  2025cites this paper
• Soluble Epoxide Hydrolase Inhibition Confers Neuroprotection via PPAR‐α Activation During Intracerebral Hemorrhage

  2025cites this paper
• A Narrative Review of the Published Pre-Clinical Evaluations: Multiple Effects of Arachidonic Acid, its Metabolic Enzymes and Metabolites in Epilepsy

  2024cites this paper
• Soluble Epoxide Hydrolase Inhibition Reverses Cognitive Dysfunction in a Mouse Model of Metabolic Syndrome by Modulating Inflammation.

  2024cites this paper
• Inhibiting the soluble epoxide hydrolase increases the EpFAs and ERK1/2 expression in the hippocampus of LiCl-pilocarpine post-status epilepticus rat model

  2024cites this paper
• Reduced neurovascular coupling is associated with increased cardiovascular risk without established cerebrovascular disease: A cross-sectional analysis in UK Biobank

  2024cites this paper
• Soluble epoxide hydrolase inhibitor (TPPU) alleviates ferroptosis by regulating CCL5 after intracerebral hemorrhage in mice.

  2024cites this paper
• CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET

  2024cites this paper
• CYP1B1 affects the integrity of the blood–brain barrier and oxidative stress in the striatum: An investigation of manganese‐induced neurotoxicity

  2024cites this paper
• Role of Inflammatory Processes in Hemorrhagic Stroke.

  2023cites this paper
• Chemical space of small molecule exploration for the elucidation of cough suppressant pharmacology of Ying Su Ke / Zi

  2023cites this paper
• Association of Arachidonic Acid–Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis

  2023cites this paper
• Fundamental neurochemistry review: Old brain stories ‐ Influence of age and sex on the neurodegeneration‐associated lipid changes

  2023cites this paper
• Novel CYP1B1-RMDN2 Alzheimers disease locus identified by genome-wide association analysis of cerebral tau deposition on PET

  2023cites this paper
• Neuroprotective Epigenetic Changes Induced by Maternal Treatment with an Inhibitor of Soluble Epoxide Hydrolase Prevents Early Alzheimer′s Disease Neurodegeneration

  2022cites this paper
• Detoxification Cytochrome P450s (CYPs) in Families 1–3 Produce Functional Oxylipins from Polyunsaturated Fatty Acids

  2022cites this paper
• Evaluation of Soluble Epoxide Hydrolase Inhibition Activity of 50 Traditional Medicinal Plants: Exploring Old Drugs for the New Pharmacological Target

  2022cites this paper
• The Role of Cytochrome P450 Enzymes in COVID-19 Pathogenesis and Therapy

  2022cites this paper
• Connexin and Pannexin Large-Pore Channels in Microcirculation and Neurovascular Coupling Function

  2022cites this paper
• Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities.

  2022cites this paper
• LC-MS/MS-based arachidonic acid metabolomics in acute spinal cord injury reveals the upregulation of 5-LOX and COX-2 products.

  2022cites this paper
• A Double-Blind, Randomized, Placebo-Controlled Trial of Soluble Epoxide Hydrolase Inhibition in Patients with Aneurysmal Subarachnoid Hemorrhage

  2021cites this paper
• Cyclooxygenase inhibition attenuates brain angiogenesis and independently decreases mouse survival under hypoxia

  2021cites this paper
• The ω-3 endocannabinoid docosahexaenoyl ethanolamide reduces seizure susceptibility in mice by activating cannabinoid type 1 receptors.

  2021cites this paper
• Role of arachidonic cascade in COVID-19 infection: A review

  2021cites this paper
• Soluble Epoxide Hydrolase Blockade after Stroke Onset Protects Normal but Not Diabetic Mice

  2021cites this paper
• Cyp2c44 epoxygenase-derived epoxyeicosatrienoic acids in vascular smooth muscle cells elicit vasoconstriction of the murine ophthalmic artery

  2021cites this paper
• Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy

  2021cites this paper
• TPPU Pre-Treatment Rescues Dendritic Spine Loss and Alleviates Depressive Behaviours during the Latent Period in the Lithium Chloride-Pilocarpine-Induced Status Epilepticus Rat Model

  2021cites this paper
• Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors.

  2021cites this paper
• Mini-review: Dissecting receptor-mediated stimulation of TRPV4 in nociceptive and inflammatory pathways

  2021cites this paper
• Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson’s Disease: A New Therapeutic Strategy

  2020cites this paper
• Cytochrome P450 Metabolism of Polyunsaturated Fatty Acids and Neurodegeneration

  2020cites this paper
• Neuroinflammation is able to downregulate cytochrome P450 epoxygenases 2J3 and 2C11 in the rat brain.

  2020cites this paper
• Epoxyeicosatrienoic acids: emerging therapeutic agents for central post-stroke pain.

  2020cites this paper
• Prolonged Soluble Epoxide Hydrolase Reactivity in Brain Endothelial Cells Is Associated with Long Cognitive Deficits in Sepsis

  2020cites this paper
• A novel interaction between soluble epoxide hydrolase and the AT1 receptor in retinal microvascular damage

  2020cites this paper
• Protective Effects of the Soluble Epoxide Hydrolase Inhibitor 1-Trifluoromethoxyphenyl-3-(1-Propionylpiperidin-4-yl) Urea in a Rat Model of Permanent Middle Cerebral Artery Occlusion

  2020cites this paper
• The Brain Oxylipin Profile Is Resistant to Modulation by Dietary n-6 and n-3 Polyunsaturated Fatty Acids in Male and Female Rats.

  2019cites this paper
• Soluble Epoxide Hydrolase Inhibitor: A Novel Potential Therapeutic or Prophylactic Drug for Psychiatric Disorders

  2019cites this paper
• NEUROBIOLOGY OF VITAMIN C: EXPANDING THE FOCUS FROM ANTIOXIDANT TO ENDOGENOUS NEUROMODULATOR.

  2019cites this paper
• Soluble Epoxide Hydrolase Inhibition Attenuates Excitotoxicity Involving 14,15-Epoxyeicosatrienoic Acid–Mediated Astrocytic Survival and Plasticity to Preserve Glutamate Homeostasis

  2019cites this paper
• Anti-inflammatory treatment with a soluble epoxide hydrolase inhibitor attenuates seizures and epilepsy-associated depression in the LiCl-pilocarpine post-status epilepticus rat model.

  2019cites this paper
• Characterization of supported liquid extraction as a sample pretreatment method for eicosanoids and related metabolites in biological fluids.

  2019cites this paper
• Dietary n-3 long chain PUFA supplementation promotes a pro-resolving oxylipin profile in the brain.

  2019cites this paper
• Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders

  2019cites this paper
• CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem

  2018cites this paper
• ASSESSMENT OF HEAVY METAL STATUS IN FRESH AND CANNED FRUITS, VEGETABLE COLLECTED FROM SUPERMARKET AND IRRIGATION FARMS

  2018influential citation
• Alterations of eicosanoids and related mediators in patients with schizophrenia.

  2018cites this paper
• Neuroprotective effects of epoxyeicosatrienoic acids.

  2018cites this paper
• Modulation of the soluble Epoxide Hydrolase enzyme as a therapeutic target against Alzheimer’s Disease

  2018cites this paper
• Age at onset of genetic (E200K) and sporadic Creutzfeldt-Jakob diseases is modulated by the CYP4X1 gene

  2018cites this paper
• Stem cell-secreted 14,15- epoxyeicosatrienoic acid rescues cholesterol homeostasis and autophagic flux in Niemann–Pick-type C disease

  2018cites this paper
• Deletion or inhibition of soluble epoxide hydrolase protects against brain damage and reduces microglia-mediated neuroinflammation in traumatic brain injury

  2017influential citation
• Microsomal cytochrome P450 as a target for drug discovery and repurposing

  2017cites this paper
• P450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection

  2017cites this paper
• CYP‐mediated drug metabolism in the brain impacts drug response

  2017cites this paper
• Anti-inflammatory ω-3 endocannabinoid epoxides

  2017cites this paper
• 11,12 ‐Epoxyeicosatrienoic acid (11,12 EET) reduces excitability and excitatory transmission in the hippocampus

  2017cites this paper
• Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage

  2017cites this paper
• Modulation of innate immunity of patients with Alzheimer's disease by omega‐3 fatty acids

  2017cites this paper
• Functional screening for G protein-coupled receptor targets of 14,15-epoxyeicosatrienoic acid.

  2017cites this paper
• Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases☆

  2017cites this paper
• A diet rich in omega-3 fatty acids enhances expression of soluble epoxide hydrolase in murine brain.

  2017cites this paper
• Soluble epoxide hydrolase as a therapeutic target for pain , in fl ammatory and neurodegenerative diseases ☆

  2017cites this paper
• Effet protecteur des acides gras polyinsaturés n-3 sur la neuroinflammation : implication des dérivés lipidiques

  2017cites this paper
• Physiology of Cerebral Blood Vessels

  2017cites this paper
• MODULATING CYTOCHROME P450-MEDIATED ARACHIDONIC ACID METABOLISM AS A POTENTIAL NEW TREATMENT MODALITY FOR CARDIAC HYPERTROPHY

  2017cites this paper
• Soluble epoxide hydrolase inhibition Promotes White Matter Integrity and Long-Term Functional Recovery after chronic hypoperfusion in mice

  2017cites this paper
• Maternal dietary imbalance between omega‐6 and omega‐3 polyunsaturated fatty acids impairs neocortical development via epoxy metabolites

  2016cites this paper
• Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke.

  2016cites this paper
• Possible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders.

  2016influential citation
• 14,15‐epoxyeicosatrienoic acid promotes production of brain derived neurotrophic factor from astrocytes and exerts neuroprotective effects during ischaemic injury

  2016cites this paper
• Targeting Soluble Epoxide Hydrolase for Temporal Lobe Epilepsy

  2016influential citation
• Soluble epoxide hydrolase: a new therapeutic target for depression

  2016cites this paper
• Beyond the classic eicosanoids: Peripherally-acting oxygenated metabolites of polyunsaturated fatty acids mediate pain associated with tissue injury and inflammation.

  2016cites this paper
• 新規脳梗塞治療薬SMTP-7 の抗炎症作用機序の解析

  2015cites this paper
• Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism.

  2015cites this paper
• Soluble Epoxide Hydrolase in Hydrocephalus, Cerebral Edema, and Vascular Inflammation After Subarachnoid Hemorrhage

  2015cites this paper
• Soluble epoxide hydrolase inhibition provides multi-target therapeutic effects in rats after spinal cord injury

  2015cites this paper
• Opioid Analgesia in P 450 Gene Cluster Knockout Mice : A Search for Analgesia-Relevant Isoforms s

  2015influential citation
• Soluble epoxide hydrolase gene deletion improves blood flow and reduces infarct size after cerebral ischemia in reproductively senescent female mice

  2015cites this paper
• Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors.

  2015cites this paper
• Soluble epoxide hydrolase inhibitor enhances synaptic neurotransmission and plasticity in mouse prefrontal cortex

  2015cites this paper
• Epoxyeicosanoid Signaling Provides Multi-target Protective Effects on Neurovascular Unit in Rats After Focal Ischemia

  2015cites this paper
• Polyunsaturated fatty acid oxygenated metabolites in skin.

  2015cites this paper
• Functional genomics indicate that schizophrenia may be an adult vascular-ischemic disorder

  2015cites this paper
• Soluble epoxide hydrolase activity regulates inflammatory responses and seizure generation in two mouse models of temporal lobe epilepsy.

  2015cites this paper
• Microsoft Word-3329786-file00.docx

  2015cites this paper
• Opioid Analgesia in P450 Gene Cluster Knockout Mice: A Search for Analgesia-Relevant Isoforms

  2015influential citation
• Structure–activity relationships of the plasminogen modulator SMTP with respect to the inhibition of soluble epoxide hydrolase

  2015cites this paper
• Role of soluble epoxide hydrolase in age-related vascular cognitive decline.

  2014cites this paper
• The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling.

  2014cites this paper
• Soluble Epoxide Hydrolase as an Anti-inflammatory Target of the Thrombolytic Stroke Drug SMTP-7*

  2014cites this paper
• Modulation of T-type calcium channels by bioactive lipids

  2014cites this paper
• Sex differences in stroke: the contribution of coagulation.

  2014cites this paper
• Prostaglandins and Other Lipid Mediators eview he role of long chain fatty acids and their epoxide metabolites in ociceptive signaling

  2014cites this paper